Filing Details
- Accession Number:
- 0001104659-21-142537
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 16:35:41
- Reporting Period:
- 2021-10-21
- Accepted Time:
- 2021-11-22 16:35:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372514 | Kiora Pharmaceuticals Inc | KPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1876429 | M. Brian Strem | C/O Kiora Pharmaceuticals, Inc. 1371 E. 2100 South, Suite 200 Salt Lake City UT 84105 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-21 | 9,517 | $0.00 | 9,517 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-11-18 | 17,853 | $1.41 | 27,370 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Footnotes
- Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.41, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
